NRx Pharmaceuticals (NASDAQ:NRXP) Earns Buy Rating from HC Wainwright
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Friday,Benzinga reports. They currently have a $19.00 price objective on the stock. A number of other research analysts have also commented on NRXP. Ascendiant Capital Markets upped their price objective […]
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Friday,Benzinga reports. They currently have a $19.00 price objective on the stock. A number of other research analysts have also commented on NRXP. Ascendiant Capital Markets upped their price objective […]
